|calgb.org > CALGB Web Site Home
|2014 NCTN TRANSITION
The National Cancer Institute (NCI) has transformed the previous NCI-sponsored Clinical Trials Cooperative Group Program that funded several separate organizations into a new consolidated and integrated program now called the NCI National Clinical Trials Network (NCTN). This new program becomes effective March 1, 2014.
The main goal of the NCTN is to conduct definitive, randomized, late phase clinical treatment trials and advanced imaging trials across a broad range of diseases and diverse patient populations. The NCTN comprises four adult network groups, one pediatric group and one Canadian collaborating clinical trials group that generate trials for the network.
The Alliance for Clinical Trials in Oncology (or Alliance) is a network group.
Here’s what Alliance members need to know about the NCTN transition.
Also for more information, visit the Alliance website at www.allianceforclinicaltrialsinoncology.org
The Cancer and Leukemia Group B Foundation invites oncology junior faculty within years 1 to 3 of a faculty appointment to apply for a research grant to support studies that assess interventions in cancer patients and/or that examine biological specimens obtained from cancer patients. Submisions are limited to research in the following areas: leukemia, lymphoma, breast, respiratory (lung), surgery, transplant, gastrointestinal, genitourinary, cancer in the elderly, pharmacology and experimental therapeutics, imaging, and cancer control and health outcomes.
This award program is being sponsored by Amgen Oncology and Millennium.
ABOUT EACH AWARD
- Up to $30,000 plus 10% overhead per year for one year
- Exclusively for oncology junior faculty at CALGB institutions (rank below Associate Professor)
- Applicant physicians must have completed training in an oncology clinical specialty (medical, surgical, radiation, gynecologic, etc.)
- Individuals must be within years 1-3 of a faculty appointment at the time of the award to be eligible.
- Projects supported by other non-institutional funds are not eligible.
There are no special forms required for this application. Each application must include the following sections:
- Cover letter - include project title, your name and title, institution name, address, phone, fax and e-mail address.
- Proposal (10-page maximum), including Specific Objectives; Background and Rationale; Preliminary Data; Research Methods; Statistical Considerations; Description of Patient Population (if applicable).
- Appendix: draft clinical trial protocol (if a therapeutic clinical trial is proposed)
- Curriculum vitae
- References (bibliographical citations)
- Applicant's other research support (include project titles, funding sources, dates, and amounts)
- Letters of support from section chief or department chair, and from research mentor
- Proposed Budget for one year with justification
APPLICATION DUE DATE: January 18, 2011
Color brochure and application application submission instructions are available at the following website:
(click on the link for junior faculty within "years 1 to 3 " of a faculty appointment in CALGB Foundation Grant Programs section)
If you are unable to submit your application electronically, contact Sylvia Hrbek at (773)702-9904.
Applications will be reviewed by an independent scientific review committee convened by the CALGB Foundation.
The award recipients will be announced at the 2011 CALGB Summer Group Meeting.
Funding will begin approximately August 1, 2011.
PLEASE FORWARD this message to appropriate candidates you know, or your department administrator who can best inform the eligible physicians at your institution of this funding opportunity.
|CALGB Results Summaries
|The Cancer and Leukemia Group B is working to make results of CALGB studies more accessible to those touched by cancer and others interested in cancer research in a reader-friendly format. Summaries highlight recently published results and provide resources for more details. To find summaries, search by type of cancer.
|Alliance for Clinical Trials in Oncology Foundation
|The Alliance for Clinical Trials in Oncology Foundation (Foundation) is a nonprofit, tax-exempt foundation that helps the Alliance for Clinical Trials in Oncology (Alliance) answer important treatment questions through large-scale clinical trials. Through efforts of the Foundation in support of Alliance clinical trials and laboratory research, donors can help find new ways to prevent, treat and cure many types of cancer, including leukemia and lymphoma, and cancers of the breast, prostate, lung and GI tract, and help educate the medical community on methods of cancer diagnosis, treatment and prevention.
Here are some recent initiatives supported by the Foundation:
- New chemotherapy treatments for breast, prostate, lung and colorectal cancer.
- New surgical techniques for breast and colon cancer.
- Genetic studies of breast cancer risk.
- Molecular determinants of response to therapy for breast, colorectal and lung cancers, and leukemia.
- Research that improves the quality of life for cancer patients and their caregivers.